奥精医疗(688613.SH):2025年三季报净利润为1394.06万元

Core Insights - The company reported a total revenue of 156 million yuan for Q3 2025, ranking 101 among disclosed peers [1] - The net profit attributable to shareholders was 13.94 million yuan, ranking 78 among disclosed peers [1] - The net cash inflow from operating activities was -4.50 million yuan, ranking 88 among disclosed peers [1] Financial Metrics - The latest debt-to-asset ratio is 6.22% [3] - The latest gross profit margin is 68.90%, a decrease of 5.56 percentage points compared to the same period last year [3] - The latest return on equity (ROE) is 0.97%, ranking 77 among disclosed peers [3] - The diluted earnings per share (EPS) is 0.10 yuan, ranking 68 among disclosed peers [3] - The latest total asset turnover ratio is 0.10 times, ranking 98 among disclosed peers [3] - The latest inventory turnover ratio is 0.69 times, a decrease of 0.35 times compared to the same period last year, representing a year-on-year decline of 33.46% [3] Shareholder Information - The number of shareholders is 9,862, with the top ten shareholders holding 51.88 million shares, accounting for 37.87% of the total share capital [3]